These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 23107479)

  • 1. Modification of a promiscuous inhibitor shifts the inhibition from γ-secretase to FLT-3.
    Amombo GM; Kramer T; Lo Monte F; Göring S; Fach M; Smith S; Kolb S; Schubenel R; Baumann K; Schmidt B
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7634-40. PubMed ID: 23107479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of gamma-secretase by the CK1 inhibitor IC261 does not depend on CK1delta.
    Höttecke N; Liebeck M; Baumann K; Schubenel R; Winkler E; Steiner H; Schmidt B
    Bioorg Med Chem Lett; 2010 May; 20(9):2958-63. PubMed ID: 20350806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural optimization of a CXCR2-directed antagonist that indirectly inhibits gamma-secretase and reduces Abeta.
    Bakshi P; Jin C; Broutin P; Berhane B; Reed J; Mullan M
    Bioorg Med Chem; 2009 Dec; 17(23):8102-12. PubMed ID: 19853461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyridine-derived γ-secretase modulators.
    Wan Z; Hall A; Sang Y; Xiang JN; Yang E; Smith B; Harrison DC; Yang G; Yu H; Price HS; Wang J; Hawkins J; Lau LF; Johnson MR; Li T; Zhao W; Mitchell WL; Su X; Zhang X; Zhou Y; Jin Y; Tong Z; Cheng Z; Hussain I; Elliott JD; Matsuoka Y
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4832-5. PubMed ID: 21742495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and preliminary evaluation of peptidomimetic inhibitors of human beta-secretase.
    Niu Y; Wang Y; Zou X; Yang X; Ma C; Lü Y; Zhou B; Yuan Y; Du G; Xu P
    Eur J Med Chem; 2010 May; 45(5):2089-94. PubMed ID: 20153560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined inhibition of integrin linked kinase and FMS-like tyrosine kinase 3 is cytotoxic to acute myeloid leukemia progenitor cells.
    Muranyi AL; Dedhar S; Hogge DE
    Exp Hematol; 2009 Apr; 37(4):450-60. PubMed ID: 19302919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and structure-activity relationship of novel [3.3.1] bicyclic sulfonamide-pyrazoles as potent γ-secretase inhibitors.
    Aubele DL; Truong AP; Dressen DB; Probst GD; Bowers S; Mattson MN; Semko CM; Sun M; Garofalo AW; Konradi AW; Sham HL; Zmolek W; Wong K; Goldbach E; Quinn KP; Sauer JM; Brigham EF; Wallace W; Nguyen L; Bova MP; Hemphill SS; Basi G
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5791-4. PubMed ID: 21885276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tripeptidic BACE1 inhibitors devised by in-silico conformational structure-based design.
    Hamada Y; Tagad HD; Nishimura Y; Ishiura S; Kiso Y
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1130-5. PubMed ID: 22178553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monosubstituted γ-lactam and conformationally constrained 1,3-diaminopropan-2-ol transition-state isostere inhibitors of β-secretase (BACE).
    Boy KM; Guernon JM; Shi J; Toyn JH; Meredith JE; Barten DM; Burton CR; Albright CF; Marcinkeviciene J; Good AC; Tebben AJ; Muckelbauer JK; Camac DM; Lentz KA; Bronson JJ; Olson RE; Macor JE; Thompson LA
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6916-24. PubMed ID: 21782431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and evaluation of tetrahydroquinoline and pyrrolidine sulfonamide carbamates as gamma-secretase inhibitors.
    Guo T; Gu H; Hobbs DW; Rokosz LL; Stauffer TM; Jacob B; Clader JW
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3010-3. PubMed ID: 17418571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo occupancy of gamma-secretase inhibitors correlates with brain beta-amyloid peptide reduction in Tg2576 mice.
    Goldstein ME; Cao Y; Fiedler T; Toyn J; Iben L; Barten DM; Pierdomenico M; Corsa J; Prasad CV; Olson RE; Li YW; Zaczek R; Albright CF
    J Pharmacol Exp Ther; 2007 Oct; 323(1):102-8. PubMed ID: 17640949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and structure-activity relationship studies of N-arylsulfonyl morpholines as γ-secretase inhibitors.
    Li H; Xu R; Cole D; Clader JW; Greenlee WJ; Nomeir AA; Song L; Zhang L
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6606-9. PubMed ID: 20933414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and X-ray crystallographic analysis of a spiropiperidine iminohydantoin inhibitor of beta-secretase.
    Barrow JC; Stauffer SR; Rittle KE; Ngo PL; Yang Z; Selnick HG; Graham SL; Munshi S; McGaughey GB; Holloway MK; Simon AJ; Price EA; Sankaranarayanan S; Colussi D; Tugusheva K; Lai MT; Espeseth AS; Xu M; Huang Q; Wolfe A; Pietrak B; Zuck P; Levorse DA; Hazuda D; Vacca JP
    J Med Chem; 2008 Oct; 51(20):6259-62. PubMed ID: 18811140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and SAR study of tricyclic sulfones as γ-secretase inhibitors: C-6 and C-8 positions.
    Su J; Tang H; McKittrick BA; Xu R; Clader JW; Greenlee WJ; Hyde L; Zhang L
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3447-51. PubMed ID: 21515050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of begacestat, a Notch-1-sparing gamma-secretase inhibitor for the treatment of Alzheimer's disease.
    Mayer SC; Kreft AF; Harrison B; Abou-Gharbia M; Antane M; Aschmies S; Atchison K; Chlenov M; Cole DC; Comery T; Diamantidis G; Ellingboe J; Fan K; Galante R; Gonzales C; Ho DM; Hoke ME; Hu Y; Huryn D; Jain U; Jin M; Kremer K; Kubrak D; Lin M; Lu P; Magolda R; Martone R; Moore W; Oganesian A; Pangalos MN; Porte A; Reinhart P; Resnick L; Riddell DR; Sonnenberg-Reines J; Stock JR; Sun SC; Wagner E; Wang T; Woller K; Xu Z; Zaleska MM; Zeldis J; Zhang M; Zhou H; Jacobsen JS
    J Med Chem; 2008 Dec; 51(23):7348-51. PubMed ID: 19012391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diamide amino-imidazoles: a novel series of γ-secretase inhibitors for the treatment of Alzheimer's disease.
    Brodney MA; Auperin DD; Becker SL; Bronk BS; Brown TM; Coffman KJ; Finley JE; Hicks CD; Karmilowicz MJ; Lanz TA; Liston D; Liu X; Martin BA; Nelson RB; Nolan CE; Oborski CE; Parker CP; Richter KE; Pozdnyakov N; Sahagan BG; Schachter JB; Sokolowski SA; Tate B; Van Deusen JW; Wood DE; Wood KM
    Bioorg Med Chem Lett; 2011 May; 21(9):2631-6. PubMed ID: 21269825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triazoles as γ-secretase modulators.
    Fischer C; Zultanski SL; Zhou H; Methot JL; Brown WC; Mampreian DM; Schell AJ; Shah S; Nuthall H; Hughes BL; Smotrov N; Kenific CM; Cruz JC; Walker D; Bouthillette M; Nikov GN; Savage DF; Jeliazkova-Mecheva VV; Diaz D; Szewczak AA; Bays N; Middleton RE; Munoz B; Shearman MS
    Bioorg Med Chem Lett; 2011 Jul; 21(13):4083-7. PubMed ID: 21616665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel gamma-secretase inhibitors uncover a common nucleotide-binding site in JAK3, SIRT2, and PS1.
    Wu F; Schweizer C; Rudinskiy N; Taylor DM; Kazantsev A; Luthi-Carter R; Fraering PC
    FASEB J; 2010 Jul; 24(7):2464-74. PubMed ID: 20237298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and SAR study of hydroxychalcone inhibitors of human β-secretase (BACE1).
    Ma L; Yang Z; Li C; Zhu Z; Shen X; Hu L
    J Enzyme Inhib Med Chem; 2011 Oct; 26(5):643-8. PubMed ID: 21222511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino-caprolactam γ-secretase inhibitors showing potential for the treatment of Alzheimer's disease.
    Neitzel ML; Aubele DL; Marugg JL; Jagodzinski JJ; Konradi AW; Pleiss MA; Szoke B; Zmolek W; Goldbach E; Quinn KP; Sauer JM; Brigham EF; Wallace W; Bova MP; Hemphill S; Basi G
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3715-20. PubMed ID: 21571529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.